| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | D06AX01 |
| UNII: | 59XE10C19C |
| InChI Key | IECPWNUMDGFDKC-MZJAQBGESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C31H48O6 |
| Molecular Weight | 516.72 |
| AlogP | 5.67 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 104.06 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 37.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Elongation factor G inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Secreted protein
|
- | - | 12000 | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 40 | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 10100-11500 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Keloid | 3 | D007627 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Infections | 2 | D007239 | ClinicalTrials |
| Skin Diseases | 2 | D012871 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 6990-06-3 |
| ChEBI | 29013 |
| ChEMBL | CHEMBL374975 |
| DrugBank | DB02703 |
| DrugCentral | 1261 |
| EPA CompTox | DTXSID0023086 |
| FDA SRS | 59XE10C19C |
| Human Metabolome Database | HMDB0015570 |
| Guide to Pharmacology | 10815 |
| PDB | FUA |
| PharmGKB | PA164749648 |
| PubChem | 3000226 |
| SureChEMBL | SCHEMBL25646 |
| ZINC | ZINC000008143796 |